By the end of 2022, will the FDA choose to exercise its enforcement discretion on regulation for tests that offer a human embryo polygenic risk score/assessment?
7
91Ṁ313
resolved Dec 17
Resolved
NO
This will stay open through 31 December 2022 and resolve on 1 January 2023 or at any earlier time that the answer is obviously yes. Note that this is for polygenic risk only, not for tests assessing monogenic traits or chromosomal abnormalities. It resolves to yes if there is action on regulation or an FDA announcement of intention to regulate or any other official indicator that the choice to proceed with regulation has been made.
Get
Ṁ1,000
to start trading!

🏅 Top traders

#NameTotal profit
1Ṁ39
2Ṁ11
3Ṁ7
4Ṁ2
5Ṁ0
Sort by:

A brief search didn't turn up anything; resolving No. If this was incorrectly resolved please let me know and post sources!

@traders Does anyone have info to support a resolution? If so I can resolve this as mod.

predictedNO

@CourtneyGrimm Can this resolve?

Do we know the correct resolution for this market?

#MyBodyMyChoice ;)
© Manifold Markets, Inc.Terms + Mana-only TermsPrivacyRules